Feeds:
Posts
Comments

Posts Tagged ‘US Preventive Services Task Force’

AMERICAN JOURNAL OF MEDICINE: To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered. READ MORE> (but you need to pay $US30 to get access to the full text).

URO TODAY: The need for this aprioristic rethinking is manifest, very eminently, in the fresh recommendations about screening for breast cancer, issued by the US Preventive Services Task Force, and in the public uproar provoked by these. READ MORE>

Read Full Post »

AAFP NEWS NOW: Men shouldn’t just rush in to get screened for prostate cancer, says a US family doctor organisation – they need to talk it over with their physician first.

The American Academy of Family Physicians is warning the world-wide Blue September prostate cancer awareness campaign may be confusing men and their doctors. READ MORE>

In recognition of September as National Prostate Cancer Awareness Month, many of your male patients (and their wives) may have been reading, hearing and seeing news reports, commercials and public service announcements encouraging men to be screened for the disease.

However, the AAFP has concluded that current evidence is insufficient to assess the balance of benefits and harms of prostate cancer screening in men younger than age 75, and the Academy actually recommends against screening men 75 and older.

Those AAFP recommendations agree with those of the US Preventive Services Task Force.

The academy quotes family physician and USPSTF member Michael LeFevre, who says the vast majority of the messages coming from professional medical and consumer health organisations and public health agencies about prostate cancer screening are consistent in saying that:

…men should be given all the information they need to make informed decisions about whether to be screened for prostate cancer.

Read Full Post »

MAY 20: URO TODAY:  The US Preventive Services Task Force recently strengthened its recommendation against screening men over 75 years old. To date, however, screening among older patients remains common, and does not adequately reflect patient life expectancy. READ MORE>

Read Full Post »